Skip to main content
CVRX
NASDAQ Industrial Applications And Services

CVRx Q2 Revenue Climbs 16% to $15.7M, but Full-Year Guidance Slashed on Sales Headwinds

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.37
Mkt Cap
$157.624M
52W Low
$4.37
52W High
$11.3
52W Position info
23% above low
Off High info
52% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CVRX sits 23% above its 52-week low of $4.37.

Summary

CVRx reported Q2 2026 revenue of $15.7M, up 16% year-over-year, but cut full-year guidance to $58M–$60M due to sales force and payer headwinds. Q3 revenue is expected to decline sequentially.

Updates

  1. · Reuters — Shares are trading near the 52-week low of $4.37, and the company has a $50M ATM program in place with a recent CFO departure.


Key Events · Earnings and Guidance · CVRX

  • Q2 Revenue Up 16% to $15.7M

    Total revenue grew 16% YoY to $15.7M, driven by 21% U.S. growth to $14.8M. U.S. revenue units increased to 466 from 391.

  • Full-Year Guidance Cut to $58M–$60M

    Management lowered 2026 revenue guidance from an implied ~$62M–$66M to $58M–$60M, citing fewer sales territories, lower productivity, and a prolonged payer challenge.

  • Q3 Revenue Expected to Decline Sequentially

    Q3 2026 revenue guidance of $13.5M–$14.5M implies a sequential drop from Q2's $15.7M, signaling near-term headwinds.

  • Net Loss Narrows Slightly to $14.0M

    Net loss was $14.0M ($0.53/share) vs. $14.7M ($0.57/share) in Q2 2025, with gross margin improving to 87% from 84%.


Analysis · CVRX · Industrial Applications And Services

CVRx posted a 16% revenue increase in Q2 2026, yet slashed its full-year outlook to $58M–$60M — a sharp drop from the ~$62M–$66M run-rate implied by Q1 results. The company pointed to fewer sales territories than planned, lower sales force productivity, and a prolonged payer challenge. Q3 guidance of $13.5M–$14.5M signals a sequential revenue decline, raising concerns about near-term momentum. Cash of $64.6M provides runway, but the lowered guidance and ongoing losses keep pressure on the stock.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CVRX was trading at $5.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $157.6M. The 52-week trading range was $4.37 to $11.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CVRX - Latest Insights

CVRX
Nov 05, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $0.621 info
Change: -$0.849 (-58%) info
Market Cap: $17.205M info
CVRX
Nov 05, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $0.621 info
Change: -$0.849 (-58%) info
Market Cap: $17.205M info
CVRX
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $0.621 info
Change: -$0.849 (-58%) info
Market Cap: $17.205M info
CVRX
Oct 02, 2026, 9:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.53
Real-time Price: $0.621 info
Change: -$0.909 (-59%) info
Market Cap: $17.205M info
CVRX
Sep 21, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.97
Real-time Price: $0.621 info
Change: -$2.35 (-79%) info
Market Cap: $17.205M info